Biotron Limited Launches $2.7 Million Rights Issue

Story Highlights
Biotron Limited Launches $2.7 Million Rights Issue

Biotron Limited ( (AU:BIT) ) has shared an update.

Biotron Limited has announced the dispatch of documents related to its rights issue, which was initially declared on February 28, 2025. The rights issue aims to raise approximately $2.7 million by offering around 902 million new shares at $0.003 each to eligible shareholders in Australia and New Zealand. The offer is open until April 1, 2025, and aims to strengthen the company’s financial position, potentially impacting its market operations and stakeholder interests.

More about Biotron Limited

Biotron Limited is a company listed on the Australian Securities Exchange (ASX: BIT), operating in the biotechnology industry. The company focuses on developing and commercializing innovative therapeutics, primarily targeting viral diseases.

YTD Price Performance: 390.0%

Average Trading Volume: 35,666

Technical Sentiment Consensus Rating: Sell

Current Market Cap: $4M

Find detailed analytics on BIT stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App